Cargando…
Safety assessment of Withania somnifera extract standardized for Withaferin A: Acute and sub-acute toxicity study
BACKGROUND: The use of Withania somnifera is increasing due to a number of its chemical constituents found useful for health. OBJECTIVE: The present study was carried out to investigate the potential adverse effects (if any) of a standardized Withania somnifera extract (WSE) in rats following acute...
Autores principales: | Patel, Shruti B., Rao, Nirav J., Hingorani, Lal L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910650/ https://www.ncbi.nlm.nih.gov/pubmed/27297507 http://dx.doi.org/10.1016/j.jaim.2015.08.001 |
Ejemplares similares
-
Sub-acute toxicity of Ashwagandha (Withania somnifera) root extract in wistar rats
por: Langade, Deepak, et al.
Publicado: (2023) -
Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology
por: Dutta, Rinku, et al.
Publicado: (2019) -
Effect of Withania somnifera hydroalcoholic extract and other dietary interventions in improving muscle strength in aging rats
por: Panda, Vandana, et al.
Publicado: (2021) -
Inhibition of VEGF: a novel mechanism to control angiogenesis by Withania somnifera’s key metabolite Withaferin A
por: Saha, Sanjib, et al.
Publicado: (2013) -
Withania Coagulans and Somnifera
por: Verghese, M.
Publicado: (1885)